Tonix Pharmaceuticals Holding Corp.
↗Chatham, New Jersey, USA
Tonix Pharmaceuticals is a fully-integrated, commercial-stage biopharmaceutical company focused on developing, licensing, and commercializing therapeutics to treat and prevent human disease. The company's pipeline is primarily focused on central nervous system (CNS) disorders, immunology, and infectious diseases, including biodefense projects.
Tonix leverages a diverse portfolio including small molecule drugs, monoclonal antibodies, and live virus vaccine platforms. The company is committed to addressing complex, chronic, and often underserved conditions, with recent milestones including the FDA approval of TONMYA for fibromyalgia.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:CNS therapeutics, Immunology, Infectious Disease
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$15M
Founded:2007
Ownership:public
Status:operating
FUNDING
Total Raised:$4.45M
STOCK
Exchange:NASDAQ
Ticker:TNXP
Market Cap:$0.18B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (TONMYA)
Modalities:Small molecule, mAb, Live virus vaccine
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Tonix Pharmaceuticals, Inc.
Key Partnerships:U.S. Department of Defense (DTRA) - antiviral development, X-Chem, Inc. - AI/ML drug discovery, Kenya Medical Research Institute (KEMRI) - vaccine clinical trial
COMPETITION
Position:Emerging
Competitors:CareDx, Adaptive Biotechnologies, BioAge Labs
LEADERSHIP
Key Executives:
Seth Lederman - CEO & Chairman
Gregory Sullivan - Chief Medical Officer
Bradley Saenger - Chief Financial Officer
Scientific Founders:Seth Lederman
LINKS
Website:tonixpharma.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Tonix Pharmaceuticals Holding Corp. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Tonix Pharmaceuticals Holding Corp.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.